Skip to main content

Table 2 Distribution of immunostaining intensity of peroxiredoxins in astrocytic tumor samples.

From: Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors

Intensity of immunostaining/peroxiredoxin

Negative

Weak

Moderate

Strong

Prx- group/

Prx+ group

Prx I

32%

47%

18%

3%

79%/21%

Prx II

16%

32%

30%

22%

48%/52%

Prx III

10%

31%

39%

20%

41%/59%

Prx IV

95%

5%

< 1%

-

100%/-

Prx V

96%

4%

-

-

100%/-

Prx VI

53%

36%

10%

1%

89%/11%

  1. For the analyses, the four categories are further divided into two groups: The Prx negative group (Prx-) contains negatively and weakly stained tumors and Prx positive group (Prx+) contains tumors showing moderate or strong immunostaining.